RxDoctor Payments Data

Lauren Panebianco, MD

Hematology & Oncology · East Syracuse, NYNPI 1770921991

Payments from drug & device makers

$240,196in general payments, 2019–2025

Across 8 payments — averaging $30,024 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$201K
  • AstraZeneca$39K
  • Welch Allyn$34
  • Gilead$12

What the payments were for

  • Education$1226%
  • Gifts$3474%

General payments by program year

20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited4$201,293
AstraZeneca2$38,857
Welch Allyn1$34
Gilead1$12

How this compares

$240,196 in reported general payments places this provider in the 80th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York

Medicare billing

Part B allowed, 2024
$1,116,205
Medicare patients
414
Services billed
58,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$12,045
Tamoxifen Citrate67$414
Anastrozole44$334

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in East Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →